Healthcare provider profile · identity verified

Omar Shaikh

Internal Medicine · EAST STROUDSBURG, PA · NPI 1033679105

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	779	234
Amlodipine Besylate	Amlodipine Besylate	517	152
Lisinopril	Lisinopril	448	121
Levothyroxine Sodium	Levothyroxine Sodium	392	109
Metformin Hcl	Metformin Hcl	368	97
Losartan Potassium	Losartan Potassium	351	103
Simvastatin	Simvastatin	301	82
Pantoprazole Sodium	Pantoprazole Sodium	257	77
Hydrochlorothiazide	Hydrochlorothiazide	252	76
Omeprazole	Omeprazole	248	74
Metoprolol Succinate	Metoprolol Succinate	238	76
Metoprolol Tartrate	Metoprolol Tartrate	215	63
Albuterol Sulfate Hfa	Albuterol Sulfate	211	57
Rosuvastatin Calcium	Rosuvastatin Calcium	209	63
Eliquis	Apixaban	185	45
Gabapentin	Gabapentin	185	66
Fluticasone Propionate	Fluticasone Propionate	184	76
Sertraline Hcl	Sertraline Hcl	158	50
Atenolol	Atenolol	157	39
Clopidogrel	Clopidogrel Bisulfate	136	45
Famotidine	Famotidine	133	39
Duloxetine Hcl	Duloxetine Hcl	102	28
Ezetimibe	Ezetimibe	102	28
Alendronate Sodium	Alendronate Sodium	100	30
Tamsulosin Hcl	Tamsulosin Hcl	99	32
Alprazolam	Alprazolam	97	22
Furosemide	Furosemide	97	34
Hydroxyzine Hcl	Hydroxyzine Hcl	95	33
Potassium Chloride	Potassium Chloride	92	23
Pravastatin Sodium	Pravastatin Sodium	82	28
Allopurinol	Allopurinol	77	24
Trazodone Hcl	Trazodone Hcl	69	18
Carvedilol	Carvedilol	67	21
Metformin Hcl Er	Metformin Hcl	67	21
Synthroid	Levothyroxine Sodium	64	17
Oxycodone Hcl	Oxycodone Hcl	62	suppressed
Jardiance	Empagliflozin	60	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	29
Trulicity	Dulaglutide	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	14
Montelukast Sodium	Montelukast Sodium	52	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	14
Lorazepam	Lorazepam	49	20
Escitalopram Oxalate	Escitalopram Oxalate	47	12
Meloxicam	Meloxicam	46	18
Ventolin Hfa	Albuterol Sulfate	45	11
Januvia	Sitagliptin Phosphate	44	12
Paroxetine Hcl	Paroxetine Hcl	44	12
Warfarin Sodium	Warfarin Sodium	43	14
Bupropion Xl	Bupropion Hcl	42	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Ozempic	Semaglutide	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	12
Fenofibrate	Fenofibrate Nanocrystallized	40	13
Glimepiride	Glimepiride	40	12
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Enalapril Maleate	Enalapril Maleate	37	11
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Mirtazapine	Mirtazapine	36	11
Fenofibrate	Fenofibrate	35	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Benazepril Hcl	Benazepril Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Digoxin	Digoxin	33	suppressed
Glipizide	Glipizide	33	11
Clonidine Hcl	Clonidine Hcl	32	13
Diclofenac Sodium	Diclofenac Sodium	32	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Clonazepam	Clonazepam	31	11
Farxiga	Dapagliflozin Propanediol	31	suppressed
Meclizine Hcl	Meclizine Hcl	30	19
Methocarbamol	Methocarbamol	30	12
Xarelto	Rivaroxaban	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	13
Celecoxib	Celecoxib	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Ibuprofen	Ibuprofen	28	15
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Valsartan	Valsartan	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Finasteride	Finasteride	24	suppressed
Invokana	Canagliflozin	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	12
Levetiracetam	Levetiracetam	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	suppressed
Nystatin	Nystatin	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Prednisone	Prednisone	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Torsemide	Torsemide	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Baclofen	Baclofen	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error